Markets › United States › NAS › KRSA

Korsana Biosciences Inc

NAS:KRSAHealth Technologynasdaq_composite

$31.41−3.00%At closeAt close · Tue 20 Oct · ≈ AED 115.35 · Market cap $1.43B · Next earnings Tue 10 Nov

Ratio	FY2021	FY2022	FY2023	FY2023	FY2025	FY2025	YoY
Operating margin	−3,539.4%	−1,400.2%	−6,242.4%	—	−181.4%	−239.8%	−58.4 pts
Net margin	−3,388.6%	−1,310.2%	−14,841.1%	—	−152.9%	−170.1%	−17.3 pts
EBITDA margin	−3,439.4%	−1,388.2%	−6,220.5%	—	−181.4%	−239.8%	−58.4 pts
Return on equity	−130.8%	−107.0%	−421.7%	−46.6%	−34.5%	−38.8%	−4.3 pts
Return on assets	−67.4%	−87.0%	−243.8%	−39.4%	−31.9%	−35.3%	−3.4 pts
Return on capital employed	−82.6%	−114.4%	−177.4%	−114.7%	−41.0%	−54.7%	−13.7 pts
Debt / equity	—	—	—	0.0×	0.0×	0.0×	—
Debt / assets	—	—	—	0.0%	0.0%	0.0%	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Current ratio	3.5×	5.0×	1.9×	3.8×	5.8×	5.2×	−11.6%
Quick ratio	3.5×	5.0×	1.9×	3.8×	5.8×	5.2×	−11.6%
Cash ratio	3.2×	4.9×	1.8×	3.6×	4.5×	3.6×	−19.2%
Asset turnover	0.0×	0.1×	0.0×	0.0×	0.2×	0.2×	−0.6%
Receivables turnover	—	39.4×	3.1×	—	3.6×	2.1×	−42.3%
Dividend payout	—	—	—	0.0%	0.0%	0.0%	—